MIR29C Gene

HGNC Family Non-coding RNAs
Name microRNA 29c
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMIR29C, a member of the miR‐29 family, has emerged as a multifunctional regulator in a wide spectrum of malignancies. In tumors such as nasopharyngeal carcinoma, chronic lymphocytic leukemia, melanoma, hepatocellular carcinoma, head and neck squamous cell carcinoma, lung, esophageal, prostate, gastric, colorectal, gallbladder, and glioma, MIR29C is frequently downregulated. Functionally, this loss alleviates its repression of key oncogenic pathways by directly targeting transcripts encoding extracellular matrix proteins (collagens, laminins, integrins, and matrix metalloproteinases), cell cycle regulators (cyclin E and CCND2), and metastasis‐promoting factors (TIAM1, LAMC1, and PHLDB2). These interactions culminate in the inhibition of cell proliferation, migration, invasion, angiogenesis, and metastatic dissemination, while restoration of MIR29C levels suppresses tumor growth and improves prognostic outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its tumor‐suppressive function, MIR29C also plays important roles in modulating cellular metabolism, epigenetic regulation, and chemoresistance. In skeletal muscle, increased MIR29C (along with its family member MIR29A) in type 2 diabetes contributes to impaired insulin signaling and altered glucose–lipid homeostasis. In renal and endometrial pathologies—as well as in cellular senescence and cardiac aging—MIR29C influences extracellular matrix remodeling, inflammatory cytokine production, and epigenetic modifications through targeting DNA methyltransferases (DNMT3A/B) or related effectors (such as SIRT1, FOXP1/ATG14, and TTP). In glioma and pancreatic cancer models, modulation of MIR29C levels can re‐sensitize chemoresistant cells by affecting downstream targets involved in cell cycle progression and apoptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, MIR29C is increasingly recognized as a valuable biomarker and effector in immunomodulation and neurodegenerative as well as other chronic disorders. In colon cancer, MIR29C functions as a direct p53 target to suppress invasion by downregulating factors such as PHLDB2, while activation of innate immune pathways (for example, via TLR3) has been shown to upregulate MIR29C, leading to promoter demethylation and the re‐expression of tumor‐suppressor genes. In gastric cancer, cytotoxic chemotherapy can induce MIR29C expression, which contributes to its anti‐metastatic effects. Finally, decreased serum levels of MIR29C have been documented in Alzheimer’s disease and diabetic nephropathy, underscoring its potential as a non‐invasive biomarker and therapeutic target in these conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "37", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Srikumar Sengupta, Johan A den Boon, I-How Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0801130105"}], "href": "https://doi.org/10.1073/pnas.0801130105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18390668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18390668"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Basile Stamatopoulos, Nathalie Meuleman, Benjamin Haibe-Kains, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-11-189407"}], "href": "https://doi.org/10.1182/blood-2008-11-189407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19144983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19144983"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Tung Nguyen, Christine Kuo, Michael B Nicholl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenetics (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/epi.6.3.14056"}], "href": "https://doi.org/10.4161/epi.6.3.14056"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21081840"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21081840"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shannon M Hawkins, Chad J Creighton, Derek Y Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional microRNA involved in endometriosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2010-0371"}], "href": "https://doi.org/10.1210/me.2010-0371"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21436257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21436257"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Chun-Mei Wang, Yan Wang, Chun-Guang Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.06.191"}], "href": "https://doi.org/10.1016/j.bbrc.2011.06.191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21763284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21763284"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "D M Cittelly, J Finlay-Schultz, E N Howe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.275"}], "href": "https://doi.org/10.1038/onc.2012.275"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22751119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22751119"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Na Liu, Ling-Long Tang, Ying Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2012.10.032"}], "href": "https://doi.org/10.1016/j.canlet.2012.10.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23142282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23142282"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mitsuhiro Matsuo, Chisato Nakada, Yoshiyuki Tsukamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-12-15"}], "href": "https://doi.org/10.1186/1476-4598-12-15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23442884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23442884"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "H J Bae, J H Noh, J K Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.216"}], "href": "https://doi.org/10.1038/onc.2013.216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23728341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23728341"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Heyong Wang, Yingchao Zhu, Mingchuan Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0070192"}], "href": "https://doi.org/10.1371/journal.pone.0070192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23936390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23936390"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Min Tan, Junjie Wu, Yong Cai "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.07.123"}], "href": "https://doi.org/10.1016/j.bbrc.2013.07.123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23939044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23939044"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yue-chao Fan, Peng-jin Mei, Chen Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-013-1223-2"}], "href": "https://doi.org/10.1007/s11060-013-1223-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23943502"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23943502"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "T Kinoshita, N Nohata, T Hanazawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2013.607"}], "href": "https://doi.org/10.1038/bjc.2013.607"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24091622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24091622"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jianan Gong, Jianxiong Li, Yi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgt337"}], "href": "https://doi.org/10.1093/carcin/bgt337"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24130168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24130168"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Rupninder Sandhu, Ashley G Rivenbark, Randi M Mackler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2013.2197"}], "href": "https://doi.org/10.3892/ijo.2013.2197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24297604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24297604"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Rika Nishikawa, Yusuke Goto, Satoko Kojima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2014.2437"}], "href": "https://doi.org/10.3892/ijo.2014.2437"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24820027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24820027"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "J X Zhang, S J Mai, X X Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdu439"}], "href": "https://doi.org/10.1093/annonc/mdu439"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25193986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25193986"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yuxuan Wang, Changzheng Liu, Min Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-0787"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-0787"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25634213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25634213"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "He Cui, Ling Wang, Pihai Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0123926"}], "href": "https://doi.org/10.1371/journal.pone.0123926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25874772"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25874772"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yi-Jun Shu, Run-Fa Bao, Lin Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2016.146"}], "href": "https://doi.org/10.1038/cdd.2016.146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28060377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28060377"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Cuijuan Shi, Linlin Ren, Cuiyun Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2017.255"}], "href": "https://doi.org/10.1038/bjc.2017.255"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28787434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28787434"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Wan Li, Jie Yi, Xiangjin Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Epigenetics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13148-018-0495-y"}], "href": "https://doi.org/10.1186/s13148-018-0495-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29796115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29796115"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Zhenhua Hu, Mingbo Cai, Ying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2019.1704537"}], "href": "https://doi.org/10.1080/15384101.2019.1704537"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31885310"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31885310"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Julie Massart, Rasmus J O Sjögren, Leonidas S Lundell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db17-0141"}], "href": "https://doi.org/10.2337/db17-0141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28404597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28404597"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Cristina Solé, Josefina Cortés-Hernández, Maria L Felip, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nephrol Dial Transplant (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ndt/gfv128"}], "href": "https://doi.org/10.1093/ndt/gfv128"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26040904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26040904"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Guoliang Lyu, Yiting Guan, Chao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-04994-z"}], "href": "https://doi.org/10.1038/s41467-018-04994-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29967491"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29967491"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Peng Du, Haiting Zhao, Renjun Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA-XIST interacts with "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-29c"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20170696"}], "href": "https://doi.org/10.1042/BSR20170696"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28831025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28831025"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Da-Peng Ding, Zhao-Li Chen, Xiao-Hong Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgr078"}], "href": "https://doi.org/10.1093/carcin/bgr078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21551130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21551130"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Guoshuai Yang, Yanmin Song, Xiaoyan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2015.3728"}], "href": "https://doi.org/10.3892/mmr.2015.3728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25955795"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25955795"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Haiyang Zhang, Ming Bai, Ting Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2016.03.026"}], "href": "https://doi.org/10.1016/j.canlet.2016.03.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27000664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27000664"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Pei Zhang, Angela Huang, Jacopo Ferruzzi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels--brief report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.111.238113"}], "href": "https://doi.org/10.1161/ATVBAHA.111.238113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22095981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22095981"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Lipin Liu, Nan Bi, Lihong Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0620-0"}], "href": "https://doi.org/10.1186/s12943-017-0620-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28241836"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28241836"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Hao Wu, Wei Zhang, Zhenru Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-1281-7"}], "href": "https://doi.org/10.1038/s41419-018-1281-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30718452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30718452"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jia Guo, Jing Li, Jing Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-01027-5"}], "href": "https://doi.org/10.1038/s41598-017-01027-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28539664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28539664"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Niraj R Joshi, Eduardo H Miyadahira, Yalda Afshar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Progesterone Resistance in Endometriosis Is Modulated by the Altered Expression of MicroRNA-29c and FKBP4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2016-2076"}], "href": "https://doi.org/10.1210/jc.2016-2076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27778641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27778641"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Yuquan Wu, Juan Xu, Jing Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tohoku J Exp Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1620/tjem.242.129"}], "href": "https://doi.org/10.1620/tjem.242.129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28626163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28626163"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Geng Chen, Tong Zhou, Yang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.04.023"}], "href": "https://doi.org/10.1016/j.bbrc.2017.04.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28392396"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28392396"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Roberta Galli, Alessio Paone, Muller Fabbri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1304610110"}], "href": "https://doi.org/10.1073/pnas.1304610110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23716670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23716670"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Hung-Yu Chien, Chang-Yi Chen, Yen-Hui Chiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.15548"}], "href": "https://doi.org/10.7150/ijms.15548"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27279796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27279796"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Limin Huang, Chaoquan Hu, Hui Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000490027"}], "href": "https://doi.org/10.1159/000490027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29807360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29807360"}]}]}]}
Synonyms MIR-29C, MIRNA29C, MIRN29C
NCBI Gene ID 407026
API
Download Associations
Predicted Functions View MIR29C's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR29C's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR29C's ARCHS4 Predicted Functions.

Functional Associations

MIR29C has 827 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.

Click the + buttons to view associations for MIR29C from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR29C gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of MIR29C gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR29C gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR29C gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR29C gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR29C gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR29C gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR29C gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR29C gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR29C gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR29C from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of MIR29C gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR29C gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR29C gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MIR29C gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR29C gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR29C gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR29C gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR29C gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR29C gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR29C gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR29C protein from the Wikipathways Pathways 2014 dataset.